Tumor cell-protective catalase as a novel target for rational therapeutic approaches based on specific intercellular ROS signaling

Anticancer Research

Volumn 32, Issue 7, 2012, Pages 2599-2624

  Bauer, Georg ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Apoptosis; Catalase; NOX1; Oncogenesis; Review; ROS; Singlet oxygen; Superoxide anion

Indexed keywords

AMITROLE; CATALASE; DEFEROXAMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; PHOTOFRIN; RAC1 PROTEIN; RAS PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SINGLET OXYGEN; SUPEROXIDE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; CANCER CELL DESTRUCTION; CANCER PREVENTION; CARCINOGENESIS; CELL TRANSFORMATION; DRUG SELECTIVITY; ENZYME INACTIVATION; HUMAN; IN VITRO STUDY; METASTASIS; MOLECULARLY TARGETED THERAPY; OXIDATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH;

CATALASE; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; REACTIVE OXYGEN SPECIES;

EID: 84865677802     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (144)

1. Weinberg RA: Oncogenes, Anti-oncogenes and the molecular basis of multistep carcinogenesis. Cancer Res 49: 3713-3721, 1989.
2. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
3. Vogelstein B and Kinzler KW: Cancer genes and the pathways they control. Nature Med 10: 789-799, 2004. (Pubitemid 39070849)
4. Temin HM: Control by factors in serum of multiplication of uninfected and cells infected and converted by avian sarcoma viruses. In: Growth Regulatory Substances for Animal Cells in Culture. Vol. 7. Defendi V and Stoker M (eds.). Philadelphia, The Wistar Symposium Monograph, Wistar Institute Press, pp. 103-116, 1967.
5. Sporn MB and Todaro GJ: Autocrine secretion and malignant transformation. New Engl J Med 303: 878-880, 1980.
6. Heldin CH and Westermark B: Growth factors as transforming proteins. Eur J Biochem 184: 487-496, 1989. (Pubitemid 19260681)
7. Stoker MGP, Shearer M and O'Neill C: Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts. J Cell Sci 1: 297-310, 1966.
8. Delinassios JG: Fibroblasts against cancer cells in vitro. Anticancer Res 7: 1005-1010, 1987.
9. Trosko JE, Chang CC, Madhukar BV and Klaunig JE: Chemical, oncogene and growth factor inhibition of gap junctional intercellular communication: an integrative hypothesis of carcinogenesis. Pathobiology 58: 265-278, 1990.
10. Barcellos-Hoff MH: It takes a tissue to make a tumor. Epigenetics, cancer and microenvironment. J Mammary Gland Biol Neoplasia 6: 213-221, 2001.
11. Flaberg E, Markasz L, Petranyi G, Stuber G, Dicso F, Alchihabi N, Olah E, Csizy I, Jozsa T, Andren O, Johansson JE, Andersson SO, Klein G and Szekely L: High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts. Int J Cancer 128: 2793-2802, 2011.
12. Deichman GI and Vendrov EL: Characteristics of in vitro transformed cells essential for their in vivo survival, selection and metastatic activity. Int J Cancer 37: 401-409, 1986. (Pubitemid 16160771)
13. Deichman GI, Kluchareva TE, Matveeva VA, Kushlinsky NE, Bassalyk LS and Vendrov EL: Clustering of discrete cell properties essential for tumorigenicity and metastasis. I. Studies of syrian hamster embryo fibroblasts spontaneously transformed in vitro. Int J Cancer 44: 904-907, 1989. (Pubitemid 20007991)
14. Deichman G, Matveeva VA, Kashkina LM, Dyakova NA, Uvarova EN, Nikiforov MA and Gudkov AV: Cell transforming genes and tumor progression: in vivo unified secondary phenotypic cell changes. Int J Cancer 75: 277-283, 1998. (Pubitemid 28100070)
15. Deichman G: Natural selection and early changes of phenotype of tumor cells in vivo: Acquisition of new defense mechanisms. Biochem (Mosc) 65: 78-94, 2000.
16. Deichman G: Early phenotypic changes of in vitro transformed cells during in vivo progression: possible role of the host innate immunity. Sem Cancer Biol 12: 317-326, 2002.
17. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91, 1996. (Pubitemid 26008141)
18. Kinzler KW and Vogelstein B: Life (and death) in a malignant tumour. Nature 379: 19-20, 1996. (Pubitemid 26008127)
19. Folkman J: Fundamental concepts of the angiogenic process. Current Mol Med 3: 643-651, 2003.
20. Bauer G: Resistance to TGF-β-induced elimination of transformed cells is required during tumor progression. Int J Oncol 6: 1227-1229, 1995.
21. Bauer G: Elimination of transformed cells by normal cells: a novel concept for the control of carcinogenesis. Histol Histopathol 11: 237-255, 1996.
22. Bauer G; Reactive oxygen and nitrogen species: efficient, selective and interactive signals during intercellular induction of apoptosis. Anticancer Res 20: 4115-4140, 2000.
23. Bauer G: Signaling and proapoptotic functions of transformed cell-derived reactive oxygen species. Prostagl Leukotri Essent Fatty Acid 66: 41-56, 2002.
24. Bauer G: Low-dose radiation and intercellular induction of apoptosis: potential implications for the control of oncogenesis. Int J Radiation Biol 83: 887-902, 2007.
25. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T and Goldschmidt-Clermont PJ: Mitogenic signalling by oxidants in Ras-transformed fibroblasts. Science 275: 1649-1652, 1997. (Pubitemid 27120541)
26. Irani K and Goldschmidt-Clermont PJ: Ras, superoxide and signal transduction. Biochem Pharmacol 55: 1339-1346, 1998. (Pubitemid 28298512)
27. Suh Y-A, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK and Lambeth JD: Cell transformation by the superoxide-generating oxidase Mox1. Nature 401: 79-82, 1999.
28. Bittinger F, Gonzalez-Garcia JL, Lein CL, Brochhausen C, Offner F and Kirkpatrick CJ: Production of superoxide by human malignant melanoma cells. Melanoma Res 8: 381-387, 1998. (Pubitemid 28530789)
29. Yang JQ, Li S, Domann FE, Buettner G and Oberley LW: Superoxide generation in v-Ha-ras-transduced human keratinocyte HaCaT cells. Mol Carcinogenesis 26: 180-188, 1999. (Pubitemid 29529569)
30. Herdener M, Heigold S, Saran M and Bauer G: Target cell-derived superoxide anions cause efficiency and selectivity of intercellular induction of apoptosis. Free Rad Biol Med 29: 1260-1271, 2000.
31. Engelmann I, Dormann S, Saran M and Bauer G: Transformed target cell-derived superoxide anions drive apoptosis induction by myeloperoxidase. Redox Report 5: 207-214, 2000.
32. Schwieger A, Bauer L, Hanusch J, Sers C, Schäfer R and Bauer G: Ras oncogene expression determines sensitivity for intercellular induction of apoptosis. Carcinogenesis 22: 1385-1392, 2001. (Pubitemid 32898694)
33. Ivanovas B and Bauer G: Selective and nonselective apoptosis induction in transformed and nontransformed fibroblasts by exogenous reactive oxygen and nitrogen species. Anticancer Res 22: 841-856, 2002. (Pubitemid 34475239)
34. Brar SS, Kennedy TP, Sturrock AB, HuecksteadtTP, Quinn MT, Whorton AR and Hoidal Jr.: An NADPH oxidase regulates growth and transcription in melanoma cells. Am J Physiol 282: C1212-C1224, 2002.
35. Heigold S, Sers C, Bechtel W, Ivanovas B, Schäfer R and Bauer G: Nitric oxide mediates apoptosis induction selectively in transformed fibroblasts compared to nontransformed fibroblasts. Carcinogenesis 23: 929-941, 2002. (Pubitemid 34752948)
36. Chamulitrat W, Schmidt R, Tomakidi P, Stremmel W, Chunglok W, Kawahara T and Rokutan K: Association of GP91PHOX homolog NOX1 with anchorage-independent growth and MAP kinase activation of transformed human keratinocyte. Oncogene 22: 6045-6053, 2003. (Pubitemid 37175882)
37. Mitsushita J, Lambeth JD and Kamata T: The superoxide-generating oxidase Nox1 is functionally required for Ras oncogenic transformation. Cancer Res 64: 3580-3585, 2004. (Pubitemid 38657935)
38. Alexandrova AY, Kopnin PB, Vasilev JM and Kopnin PB: Ros up-regulation mediates Ras-induced changes of cell morphology and motility. Exp Cell Res 312: 2066-2073, 2006. (Pubitemid 43850931)
39. Laurent E, McCoy JW, Maccina RA, Liu W, Cheng GJ, Robine S, Papkoff J and Lambeth JD: Nox1 is overexpressed in human colon cancers and correlates with activating mutations in K-Ras. Int J Cancer 123: 100-107, 2008. (Pubitemid 351705197)
40. Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, Hala LP, Dong C, Cesarman E, Mesri EA and Goldschmidt-Clermont PJ: Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proc Natl Acad Sci USA 106: 8683-8688, 2009.
41. Kim E-Y, Seo J-M, Kim C, Lee J-E, Lee K-M and Kim J-H: BLT2 promotes the invasion and metastasis of aggressive bladder cancer through a reactive oxygen species-linked pathway. Free Rad Biol Med 49: 1072-1081, 2010.
42. Du J, Liu J, Smith BJ, Tsao MS and Cullen J: Role of rac-1-dependent NADPH oxidase in the growth of pancreatic cancer. Cancer Gene Therapy 18: 135-143, 2011.
43. Behrend L, Henderson G and Zwacka RM: Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 31: 1441-1444, 2003. (Pubitemid 38030996)
44. Geiszt M and Leto L: The nox family of NAD(P)H oxidases: host defense and beyond. J Biol Chem 279: 51715-51718, 2004. (Pubitemid 39656535)
45. Bedard K and Krause KH: The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313, 2007. (Pubitemid 46209993)
46. Lambeth JD: Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Rad Biol Med 43: 332-347, 2007.
47. Lopez-Lazaro M: Excessive superoxide anion generation plays a key role in carcinogenesis. Int J Cancer 120: 1378-1380, 2007.
48. Kamata T: Roles of Nox1 and other Nox isoforms in cancer development. Cancer Sci 100: 1382-1388, 2009.
49. Weinberg F and Chandel NS: Reactive oxygen species-dependent signaling regulates cancer. Cell Mol Life Sci 66: 3663-3673, 2009.
50. Engelmann I, Eichholtz-Wirth H and Bauer G: Ex vivo tumor cell lines are resistant to intercellular induction of apoptosis and independent of exogenous survival factors. Anticancer Res 20: 2361-2370, 2000. (Pubitemid 30614438)
51. Engelmann I and Bauer G: How can tumor cells escape intercellular induction of apoptosis? Anticancer Res 20: 2297-2306, 2000. (Pubitemid 30614429)
52. Bechtel W and Bauer G: Catalase protects tumor cells against apoptosis induction by intercellular ROS signaling. Anticancer Res 29: 4541-4557, 2009.
53. Bechtel W and Bauer G: Modulation of intercellular ROS signaling of human tumor cells. Anticancer Res 29: 4559-4570, 2009
54. Heinzelmann S and Bauer G: Multiple protective functions of catalase against intercellular apoptosis-inducing ROS signaling of human tumor cells. Biol Chem 391: 675-693, 2010.
55. Lopez-Lazaro M: Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett 252: 1-8, 2007.
56. Cheng G, Diebold BA, Hughes Y and Lambeth JD: Nox1-dependent reactive oxygen generation is regulated by Rac1. J Biol Chem 281: 17718-17726, 2006. (Pubitemid 44035570)
57. Arnold RS, Shi J, Murad E, Whalen AM, Sun CQ, Palavarapu R, Parthasarathy S, Petros JA and Lambeth JD: Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc Natl Acad Sci USA 98: 5550-5555, 2001. (Pubitemid 32435679)
58. Shinohara M, Shang W-H, Kubodera M, Hanada S, Mitsushita J, Kato M, Miyazaki H, Suminoto H and Kamata T: Nox1 redox signaling mediates oncogenic Ras -induced disruption of stress fibers and focal adhesions by down-regulating Rho. J Biol Chem 282: 17640-17648, 2007. (Pubitemid 47100324)
59. Sadok A, Bourgarel-Rey V, Gattacceca F, Penel C, Lehmann M and Kovacic H: Nox1-dependent superoxide production controls colon adenocarcinoma cell migration. Biochem Biophys Acta 1783: 23-33, 2008.
60. Tominaga K, Kawahara T, Sano t, Toida K, Kuwano Y, Sasaki H and Kawai T: Evidence for cancer-associated expression of NADPH oxidase 1 (Nox1)-base oxidase system in the human stomach. Free Rad Biol Med 43: 1627-1638, 2007. (Pubitemid 350122987)
61. Liu SY, Yen CY, Yang SC anc Chiang WF: Overexpression of Rac-1 small GTPase-binding protein in oral squamous cell carcinoma. J Oral Maxillofac Surg 62: 702-707, 2004.
62. Hwang SL, Hong YR, Sy WD, Lieu AS, Lin CL, Lee KS and Howng SL: Rac1 gene mutations in human brain tumors. Eur J Surg Oncol 30: 68-72, 2004. (Pubitemid 38180994)
63. Arbiser JL, Petros J, Klafter R, Govindajaran B, McLaughlin ER, Brown LF, Cohen C, Moses M, Kilroy S, Arnold RS and Lambeth JD: Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Acad Natl Acad Sci USA 99: 715-720, 2002. (Pubitemid 34106576)
64. Blanchetot C and Boonstra J: The ROS-NOX connection in cancer and angiogenesis. Crit Rev Euk Gene Expr 18: 35-45, 2008. (Pubitemid 350259933)
65. Ferraro D, Corso S, Fasano E, Panieri E, Santangelo R, Borrelo S, Giordano S, Pani G and Galeotti T: Pro-metastatic signaling by c-Met through Rac-1 and reactive oxygen species. Oncogene 25: 3689-3698, 2006. (Pubitemid 43980490)
66. Lopez-Lazaro M: Why do tumors metastasize? Cancer Biol Ther 6: 141-144, 2007.
67. Chiera F, Meccia E, Degan P, Aquilina G, Pietraforte D, Minetti M, Lambeth D and Bignami M: Overexpression of human NOX1 complex induces genome instability in mammalian cells. Free Rad Biol Med 44: 332-342, 2008.
68. Jürgensmeier J, Schmitt CP, Viesel E, Höfler P and Bauer G: TGF-β-treated normal fibroblasts eliminate transformed fibroblasts by induction of apoptosis. Cancer Res 54: 393-398, 1994.
69. Jürgensmeier J, Höfler P and Bauer G: TGF-β-induced elimination of transformed fibroblasts by normal cells: independence of cell-to-cell contact and dependence on reactive oxygen species. Int J Oncology 5: 525-531, 1994.
70. Schaefer D, Jürgensmeier J and Bauer G: Catechol interferes with TGF-β-induced elimination of transformed cells by normal cells: implications for the survival of transformed cells during carcinogenesis. Int J Cancer 60: 520-526, 1995.
71. Langer C, Jürgensmeier JM and Bauer G: Reactive oxygen species act both at TGF-β-dependent and -independent steps during induction of apoptosis of transformed cells by normal cells. Exp Cell Res 222: 117-124, 1996. (Pubitemid 26043717)
72. Hipp M-L and Bauer G: Intercellular induction of apoptosis in transformed cells does not depend on p53. Oncogene 15: 791-797, 1997.
73. Jürgensmeier J and Bauer G: Interference of Bcl-2 with intercellular control of carcinogenesis. Int J Cancer 71: 698-704, 1997.
74. Panse J, Hipp M-L and Bauer G: Fibroblasts transformed by chemical carcinogens are sensitive for intercellular induction of apoptosis: implications for the control of oncogenesis. Carcinogenesis 18: 259-264, 1997. (Pubitemid 28132416)
75. Beck E, Schäfer R and Bauer G: Sensitivity of transformed fibroblasts for intercellular induction of apoptosis is determined by their transformed phenotype. Exp Cell Res 234: 47-56, 1997. (Pubitemid 27317901)
76. Zucker B and Bauer G: Intercellular induction of apoptosis of transformed cells is modulated by their intracellular glutathione concentration. Int J Oncol 10: 141-146, 1997. (Pubitemid 26426668)
77. Eckert S and Bauer G: TGF-β isoforms and fibroblast growth factor exhibit analogous indirect antioncogenic activity through triggering of intercellular induction of apoptosis. Anticancer Res 18: 45-52, 1998. (Pubitemid 28174683)
78. Dormann S and Bauer G: TGF-β and FGF trigger intercellular induction of apoptosis: analogous activity on non-transformed but differential activity on transformed cells. Int J Oncol 13: 1247-1252, 1998.
79. Von Eynatten K and Bauer G: Central and ambivalent role of hydrogen peroxide during intercellular induction of apoptosis. Int J Oncol 18: 1169-1174, 2001.
80. Bauer G, Chatgilialoglu C, Gebicki JL, Gebicka L, Gescheidt G, Golding BT, Goldstein S, Kaizer J, Merenyi G, Speier G and Wardman P: Biologically relevant small radicals. Chimia 62: 1-9, 2008.
81. Saran M and Bors W: Oxygen radicals as chemical messengers: a hypothesis. Free Rad Res Comm 7: 213-220, 1989. (Pubitemid 19281968)
82. Steinmann M, Moosmann N, Schimmel M, Gerhardus C and Bauer G: Differential role of extra- and intracellular superoxide anions for nitric oxide-mediated apoptosis induction. In Vivo 18: 293-310, 2004. (Pubitemid 39069745)
83. Steinebach C and Bauer G: An alternative signalling pathway based on nitryl chloride during intercellular induction of apoptosis. In Vitro Appl Mol Toxicol 14: 107-120, 2001. (Pubitemid 32867900)
84. Schimmel M and Bauer G: Proapoptotic and redox state-related signalling of reactive oxygen species generated by transformed fibroblasts. Oncogene 21: 5886-5896, 2002. (Pubitemid 35007239)
85. Kundrát P, Bauer G, Jacob P and Friedland W:. Mechanistic modelling suggests that the size of preneoplastic lesions is limited by intercellular induction of apoptosis in oncogenically transformed cells. Carcinogenesis 33: 253-259, 2012.
86. Teoh MLT, Sun W, Smith BJ, Oberley LW and Cullen AJ: Modulation of reactive oxygen species in pancreatic cancer. Clin Cancer Res 13: 7441-7450, 2007.
87. Sarsour EH, Venkataraman S, Kalen AL, Oberley LW and Gowami PC: Manganese superoxide dismutase activity regulates transitions between quiescent and proliferative growth. Aging Cell 7: 405-417, 2008. (Pubitemid 351663909)
88. Policastro L, Molinari B, Larcher F, Blanco P, Podhajcer OL, Costa CS, Rojas P and Durn H: Imbalance of antioxidant enzymes in tumor cells and inhibition of proliferation and malignant features by scavenging hydrogen peroxide. Mol. Carcinogenesis 39: 103-113, 2004. (Pubitemid 38167114)
89. Burdon RH: Superoxide and hydrogen peroxide in relation to mammalian cell proliferation Free Rad Biol Medicine 18: 775-794, 1995.
90. Droge W: Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
91. Ammendola R, Ruocchio MR, Chirico G, Russo L, De Felice C, Esposito F, Russo T and Cimino F: Inhibition of NADH/NADPH oxidase affects signal transduction by growth factor receptors in normal fibroblasts. Arch Biochem Biophys 397: 253-257, 2002. (Pubitemid 34852288)
92. Long CA and Bielski BH: Rate of reaction of superoxide radical with chloride-containing species. J Phys Chem 84: 555-557, 1980.
93. Candeias LP, Patel KB, Stratford MRL and Wardmann P: Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid. FEBS 333: 151-153, 1993. (Pubitemid 23306958)
94. Folkes LK, Candeias LP and Wardman P: Kinetics and mechanisms of hypochlorous acid reactions. Arch Biochem Biophys 323: 120-126, 1995.
95. Saran M and Bors W: Signalling by O2 - and NO: How far can either radical, or any specific reaction product, transmit a message under in vivo conditions? Chem Biol Interact 90: 35-45, 1994. (Pubitemid 24087505)
96. Saran M, Michel C and Bors W: Radical functions in vivo: a critical review of current concepts and hypotheses. Zeitschr Naturforsch 53 c: 210-227, 1998.
97. Moncada S and Higgs EA: The L-arginine-nitric oxide pathway. New Engl J Med 329: 2002-2012, 1993. (Pubitemid 24015045)
98. Dawson TM and Dawson VL: Nitric oxide: action and pathological roles. Neuroscientist 1: 17-18, 1995.
99. Saran M, Michel C and Bors W: Reaction of NO with O2-. Implication for the action of endothelium-derived relaxing factor (EDRF). Free Rad Res Comm 10: 221-226, 1990.
100. Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H and Beckman JS: Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol 5: 834-842, 1992. (Pubitemid 23004874)
101. Huie RE and Padmaja S: The reaction of NO with superoxide. Free Rad Res Comm 18: 195-199, 1993.
102. Pryor WA and Squadrito GL: The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 268: L699-L722, 1995.
103. Gatti RM, Alvarez B, Vasquez-Vivar J, Radi R and Augusto O: Formation of spin trap adducts during the decomposition of peroxynitrate. Arch Biochem Biophys 349: 36-46, 1998. (Pubitemid 28368388)
104. Merenyi G and Lind J: Free radical formation in the peroxynitrous acid (ONOOH)/peroxynitrite (ONOO-) system. Chemical Res Toxicol 11: 243-246, 1998.
105. Edens WA, Sharling L, Cheng G, Shapira R, Kinkade J, Lee T, Edens H, Tang X, Sullards C, Flaherty DB, Benian GM und Lambeth JD: Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J Cell Biol 154: 879-891, 2001. (Pubitemid 34292967)
106. Lambeth JD: NOX enzymes and the biology of reactive oxygen. Nature Rev Immunol 4: 181-189, 2004.
107. Donkó A, Zalán P, Sum A, Leto T und Geiszt M: Dual Oxidases. Phil Trans R Soc 360: 2301-2308, 2005.
108. Santiskulvong C and Rozengurt E: Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cells. Exp Cell Res 290: 437-446, 2003. (Pubitemid 37272186)
109. Gardner PR, Martin LA, Hall D and Gardner AM: Dioxygen-dependent metabolism of nitric oxide in mammalian cells. Free Rad Biol Med 31: 191-204, 2001 (Pubitemid 32607586)
110. Schmidt K and Mayer B. Consumption of nitric oxide by endothelial cells: Evidence for the involvement of a NAD(P)H-, flavin and heme-dependent dioxygenase reaction. FEBS Lett 577: 199-204, 2004. (Pubitemid 39452384)
111. Hallstrom CK, Gardner AM and Gardner PR: Nitric oxide metabolism in mammalian cells: substrate and inhibitor profiles of a NADPH-cytochrome P450 oxidoreductase-coupled microsomal nitric oxide dioxygenase. Free Rad Biol Med 37: 216-228, 2004. (Pubitemid 38760258)
112. Gardner PR: Assay and characterization of the NO dioxygenase activity of flavohemoglobins. In: Globins and Other Nitric Oxide-reactive Proteins. Meth Enzymol 436: 217-237, 2008.
113. Gebicka, L. and Didil J: Catalytic scavenging of peroxynitrite by catalase. Int J Inorg Biochem 103: 1375-1379, 2009.
114. Kono Y, Yamasaki T, Ueda A and Shibata H: Catalase catalyzes of peroxynitrite-mediated phenolic nitration. Biosci Biotechnol Biochem 62: 448-452, 1998. (Pubitemid 128474946)
115. Brown GC: Reversible binding and inhibition of catalase by nitric oxide. Eur J Biochem 232: 188-191, 1995.
116. Brunelli L, Yermilov V and Beckman JS. Modulation of catalase peroxidatic and catalytic activity by nitric oxide. Free Rad Biol Med 30: 709-714, 2001. (Pubitemid 32245576)
117. Ophoven SJ and Bauer G: Salen-manganese complexes: sophisticated tools for the study of intercellular ROS signaling. Anticancer Res 30: 3967-3980, 2010.
118. Clark RA, Klebanoff SJ, Einstein AB and Fefer A: Peroxidase - H2O2- halide system: cytotoxic effect on mammalian tumor cells. Blood 45: 161-170, 1975.
119. Clark RA and Klebanoff SJ: Neutrophil-mediated tumor cell cytotxicity - role of peroxidase system. J Exp Med 141: 1442-1447, 1975.
120. Okajima T, Onishi M, Hayama E, Motoji N and Momose Y: Cytolysis of B-16 melanoma tumor cells mediated by the myeloperoxidase and lactoperoxidase systems. Biol Chem 377: 689-693, 1996. (Pubitemid 26418093)
121. Blatt J: Deferoxamine in children with recurrent neuroblastoma. Anticancer Res 14: 2109-2112, 1994.
122. Blatt J and Wharton V: Stimulation of growth of neuroblastoma cells by ferritin in vitro. J. Lab Clin Med 119: 139-143, 1992.
123. Di Mascio P, Bechara EJH, Medeiros MHG, Briviba K and Sies H: Singlet molecular oxygen production in the reaction of peroxynitrite with hydrogen peroxide. FEBS Lett 355: 287-289, 1994.
124. Escobar JA, Rubio A and Lissi EA: SOD and catalase inactivation by singlet oxygen and peroxyl radicals. Free Rad Biol Med 20: 285-290, 1996. (Pubitemid 26077850)
125. Kim YK, Kwon OJ and Park J-W: Inactivation of catalase and superoxide dismutase by singlet oxygen derived from photoactivated dye. Biochimie 83: 437-444, 2001. (Pubitemid 32466059)
126. Fita I and Rossmann MG: The active center of catalase. J Mol Biol 185: 21-37, 1985. (Pubitemid 16250043)
127. Zhuang S, Demir JT and Kochevar IE: Protein kinase C inhibits singlet oxygen-induced apoptosis by decreasing caspase-8 activation. Oncogene 20: 6764-6776, 2001. (Pubitemid 33020605)
128. Suzuki Y, Ono Y and Hirabayashi Y: Rapid and specific reactive oxygen species generation via NADPH oxidase activation during FAS-mediated apoptosis. FEBS Lett 425: 209-212, 1998. (Pubitemid 28178891)
129. Reinehr R, Becker S, Eberle A, Grether-Beck S and Häussinger D: Involvement of NADPH oxidase isoforms and src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem 280: 27179-27194, 2005.
130. Selleri C, Sato T, Raiola AM, Rotoli B, Young NS and Maciejewski JP. Induction of nitric oxide synthase is involved in the mechanism of FAS-mediated apoptosis in hematopoietic cells. Br J Hematol 99: 481-489, 1997. (Pubitemid 27519844)
131. Miyamoto S, Ronsein GE, Prado FM, Uemi M, Correa TC, Toma IN, Bertolucci A, Oliveira MCB, Motta FD, Medeiros MHG and Di Mascio P: Biological hydroperoxides and singlet molecular oxygen generation. IUBMB LIFE 59: 322-331, 2007. (Pubitemid 46763765)
132. Di Mascio P, Briviba K, Sasaki ST, Catalani LH, Medeiros MHG, Bechara EJH and Sies H: The reaction of peroxynitrite with tert-butyl hydroperoxide produces singlet molecular oxygen. Biol Chem 376: 1071-1074, 1997. (Pubitemid 27438031)
133. Pelicano H, Carney D and Huang P: ROS stress in cancer cells and therapeutic implications. Drug Resist Updates 7: 97-110, 2004. (Pubitemid 38736063)
134. Bonavida B, Khineche S, Huerta-Ypez S and Garban H: Therapeutic potential of nitric oxide in cancer. Drug Resist Updates 9: 157-173, 2006. (Pubitemid 44294871)
135. Hirst D and Robson T: Targeting nitric oxide for cancer therapy. J Pharm Pharmacol 59: 3-13, 2006.
136. Hirst DG and Robson T: Nitrosative stress in cancer therapy. Front Biosci 12: 3406-3418, 2007.
137. Halliwell B: Oxidative stress and cancer: Have we moved forward? Biochem J 401: 1-11, 2007.
138. Lambeth JD, Krause KH and Clark RA: NOX enzymes as novel targets for drug development. Sem Immunopathol 30: 339-363, 2008.
139. Ushuio-Fukai M and Nakamura Y: Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266: 37-52, 2008.
140. Mocellin S: Nitric oxide: Cancer target or anticancer agent? Curr Cancer Drug Targ 9: 214-236, 2009.
141. Trachootham D, Alexandre J and Huang P: Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nature Rev Drug Discov 8: 579-591, 2009.
142. Wondrak GT: Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal 11: 3013-3069, 2009.
143. Maciag AE, Chaprapani H, Saavedra J, Morris NL, Holland RJ, Kosak KM, Shami P, Anderson LM and Keefer LK: The nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: Involvement of reactive oxygen species. J Pharmacol Exp Ther 336: 313-320, 2011.
144. Kim MY: Nitric oxide triggers apoptosis in A375 human melanoma cells treated with capsaicin and resveratrol. Mol Med Reports 5: 585-591, 2012.